ArticleNano select : open access2022

Broad antiviral and anti-inflammatory efficacy of nafamostat against SARS-CoV-2 and seasonal coronaviruses in primary human bronchiolar epithelia.

Brian F Niemeyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.